Speakers: Marc Verhaeren (co-founder & CEO at Studia), Patrica van Dijck (Political & Medical Director Pharma.be)
In this discussion, we will step back from the day-to-day operational challenges and examine the evolving clinical research landscape through a strategic lens. Together, we will explore whether regulatory frameworks are keeping pace with innovation, how they influence competitiveness and investment decisions, and what Belgium can do to strengthen its position as a leading destination for clinical research. The conversation will focus on identifying opportunities to build on our strengths while addressing the barriers that may limit future growth and innovation.
